List view / Grid view
Bristol-Myers Squibb Company announced a number of leadership changes approved…
21 January 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a number of leadership changes approved by its board of directors and effective at the close of the annual Shareholders’ Meeting on May 5...
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D.,…
Bristol-Myers Squibb Company (NYSE:BMY) today announced that Giovanni Caforio, M.D., has been appointed chief operating officer and elected to Bristol-Myers Squibb’s Board of Directors, effective June 5, 2014. He will continue to report to Lamberto Andreotti, chief executive officer. In addition to his current responsibilities as chief commercial officer, Caforio…
Global license and two year collaboration for Recothrom®...
12 December 2012 | By Bristol-Myers Squibb Company
Global license and two year collaboration for Recothrom®...
Bristol-Myers Squibb Company announced a series of related changes within…
19 October 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a series of related changes within its Senior Management Team...
